CALL
Monday – Friday
8:00 a.m. – 4:00 p.m.
Tel. + 48 (22) 811 18 14
What is an adverse reaction?
An adverse drug reaction (ADR) is any unintended reaction to a medicine. It is any unpleasant, disturbing or harmful response to a medicine that occurs during or after treatment.
How to report an adverse reaction?
Please report any adverse reactions you observe, as well as any other information regarding the use of our medicinal products, using your preferred method of contact.
ONLINE
Please send the completed form available below to the following address:
POST
Please send the completed form available below to the following address:
Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.
Pharmacovigilance Department
A. Fleminga 2 Street, 03-176 Warsaw
Report adverse reactions by filling out the FCS form (for patients or patient caregivers) or the CIOMS form (for healthcare professionals) available below.
Forms to download
The report must include
the name of the medicinal product suspected of causing the adverse reaction
the initials, age or gender of the patient concerned
a description of the adverse reaction
your name and surname
Important information
We encourage you to provide as detailed a description of the adverse reaction as possible. Any information may prove extremely valuable in establishing a cause-and-effect relationship between the medicinal product and the adverse reaction.
Please report all symptoms that seem inappropriate, even if you are unsure about the relationship between their occurrence and the medicine being taken.
Please inform us about cases of use of our medicines during pregnancy, breastfeeding and other reports related to the safety of our products.
IMPORTANT! The contact details provided are not for medical advice or consultation purposes. If you are currently experiencing worrying symptoms, please contact your doctor or other healthcare professional first.
If you require urgent medical intervention, please contact your doctor or emergency services by calling 112.
Information on the processing of personal data is available in the Privacy Policy – Reporting Adverse Drug Reactions
Message for the patient
-
09.10.2025Message for the patientAvailability of Elenium
Warsaw, October 7, 2025 Dear Sir or Madam, In connection with the administrative decision of the Main Pharmaceutical Inspectorate concerning the withdrawal from the market of specific batches of the medicinal product Elenium 5 mg, coated tablets Elenium 10 mg, coated tablets Elenium 25 mg, coated tablets we would like to provide you with the […]